59 related articles for article (PubMed ID: 29542372)
1. Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.
Fedele AL; Petricca L; Tolusso B; Alivernini S; Canestri S; Di Mario C; Bosello SL; Ferraccioli G; Gremese E
Scand J Rheumatol; 2018 Sep; 47(5):351-359. PubMed ID: 29542372
[TBL] [Abstract][Full Text] [Related]
2. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.
Rydell E; Forslind K; Nilsson JÅ; Jacobsson LTH; Turesson C
Arthritis Res Ther; 2018 May; 20(1):82. PubMed ID: 29720260
[TBL] [Abstract][Full Text] [Related]
3. Influence of rheumatoid factor on serum drug levels of TNF inhibitors with different structures in rheumatoid arthritis.
Martínez-Feito A; Plasencia-Rodríguez C; Novella-Navarro M; Gehin JE; Hernández-Breijo B; Brenis CM; Villalba-Yllán A; Fernández E; Monjo-Henry I; Pascual-Salcedo D; Nozal P; Balsa A
Clin Exp Rheumatol; 2024 May; 42(5):999-1005. PubMed ID: 38197184
[TBL] [Abstract][Full Text] [Related]
4. Differences in referral path, clinical and radiographic outcomes between seronegative and seropositive rheumatoid arthritis Mexican Mestizo patients: A cohort study.
Guaracha-Basáñez GA; Contreras-Yáñez I; Ortiz-Haro AB; Pascual-Ramos V
PLoS One; 2024; 19(6):e0304953. PubMed ID: 38843126
[TBL] [Abstract][Full Text] [Related]
5. Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis.
Reams J; Berger A; Denio A
Medicine (Baltimore); 2020 Aug; 99(35):e21827. PubMed ID: 32871905
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Study of the Development of Inflammatory Arthritis in the Family Members of Indigenous North American People With Rheumatoid Arthritis.
Tanner S; Dufault B; Smolik I; Meng X; Anaparti V; Hitchon C; Robinson DB; Robinson W; Sokolove J; Lahey L; Ferucci ED; El-Gabalawy H
Arthritis Rheumatol; 2019 Sep; 71(9):1494-1503. PubMed ID: 30861615
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis.
Shin YS; Choi JH; Nahm DH; Park HS; Cho JH; Suh CH
Yonsei Med J; 2005 Aug; 46(4):464-70. PubMed ID: 16127769
[TBL] [Abstract][Full Text] [Related]
8. A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients.
Syversen SW; Goll GL; Haavardsholm EA; Bøyesen P; Lea T; Kvien TK
Arthritis Res Ther; 2008; 10(2):R28. PubMed ID: 18312691
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.
Greenwood M; Shipa M; Yeoh SA; Roussou E; Mukerjee D; Ehrenstein MR
Ann Rheum Dis; 2020 Nov; 79(11):1516-1517. PubMed ID: 32467248
[No Abstract] [Full Text] [Related]
10. Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis.
Sahatciu-Meka V; Rexhepi S; Manxhuka-Kerliu S; Rexhepi M
Bosn J Basic Med Sci; 2010 Feb; 10(1):26-31. PubMed ID: 20192927
[TBL] [Abstract][Full Text] [Related]
11. Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study.
Figueroa-Parra G; Gilbert EL; Valenzuela-Almada MO; Vallejo S; Neville MR; Patel NJ; Cook C; Fu X; Hagi R; McDermott GC; Dilorio MA; Masto L; Vanni KMM; Kowalski E; Qian G; Zhang Y; Wallace ZS; Duarte-García A; Sparks JA
Lancet Rheumatol; 2022 Nov; 4(11):e765-e774. PubMed ID: 36118532
[TBL] [Abstract][Full Text] [Related]
12. Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: Results From a Randomized, Controlled Trial.
Kremer JM; Rigby W; Singer NG; Birchwood C; Gill D; Reiss W; Pei J; Michalska M
Arthritis Rheumatol; 2018 Aug; 70(8):1200-1208. PubMed ID: 29575803
[TBL] [Abstract][Full Text] [Related]
13. Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
Ebina K; Hashimoto M; Yamamoto W; Ohnishi A; Kabata D; Hirano T; Hara R; Katayama M; Yoshida S; Nagai K; Son Y; Amuro H; Akashi K; Fujimura T; Hirao M; Yamamoto K; Shintani A; Kumanogoh A; Yoshikawa H
PLoS One; 2018; 13(3):e0194130. PubMed ID: 29543846
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study.
Haroon M; Ahmad M; Baig MN; Mason O; Rice J; FitzGerald O
Arthritis Res Ther; 2018 Apr; 20(1):73. PubMed ID: 29665824
[TBL] [Abstract][Full Text] [Related]
16. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2).
Gottlieb AB; Blauvelt A; Thaçi D; Leonardi CL; Poulin Y; Drew J; Peterson L; Arendt C; Burge D; Reich K
J Am Acad Dermatol; 2018 Aug; 79(2):302-314.e6. PubMed ID: 29660421
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
Choi S; Lee KH
PLoS One; 2018; 13(4):e0195550. PubMed ID: 29624625
[TBL] [Abstract][Full Text] [Related]
19. The association of obesity with disease activity, functional ability and quality of life in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Study/Early Rheumatoid Arthritis Network UK prospective cohorts.
Nikiphorou E; Norton S; Young A; Dixey J; Walsh D; Helliwell H; Kiely P;
Rheumatology (Oxford); 2018 Jul; 57(7):1194-1202. PubMed ID: 29590474
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study.
Suda M; Ohde S; Tsuda T; Kishimoto M; Okada M
Clin Rheumatol; 2018 Aug; 37(8):2027-2034. PubMed ID: 29582252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
